AndreaCercekMD

Instructor, Medicine, Weill Cornell Medical College

Overview of Dr. Cercek

Dr. Andrea Cercek is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from New York Medical College and has been in practice 13 years. She is one of 464 doctors at Memorial Sloan Kettering Cancer Center and one of 62 doctors at NYC Health + Hospitals / Bellevue who specialize in Oncology. She also speaks multiple languages, including Spanish. She has more than 100 publications and over 500 citings.

Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021
Book by Phone+1(215) 392-4802
Is this information wrong?

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
New York Medical CollegeClass of 2004

Certifications & Licensure

FL State Medical License 2021 - Present
NJ State Medical License 2020 - 2025
NY State Medical License 2006 - 2024
NC State Medical License 2020 - 2022
American Board of Internal Medicine Medical Oncology

Clinical Trials

Clinical and Translational Study of STA-9090 Start of enrollment: 2010 Apr 01
Completed
Phase 2
A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours Start of enrollment: 2011 Jan 01
Completed
Phase 1
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma Start of enrollment: 2013 Sep 05
Completed
Phase 1
Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma Start of enrollment: 2013 Dec 01
Active, not recruiting
Phase 2
Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer Start of enrollment: 2017 Jun 23
Completed
Phase 2
Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver Start of enrollment: 2017 Feb 28
Withdrawn
Phase 2
Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma Start of enrollment: 2017 Oct 05
Terminated
Phase 1, Phase 2
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial Start of enrollment: 2020 Apr 20
Terminated
Collection of Information to Better Understand Young Onset Colorectal Cancer Start of enrollment: 2020 Jul 22
Recruiting
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery Start of enrollment: 2021 May 07
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer.
Emily Harrold, Fergus Keane, Henry Walch, Joanne F Chou, Jenna Sinopoli, Silvia Palladino, Duaa H Al-Rawi, Kalyani Chadalavada, Paolo Manca, Sree Chalasani, Jessica Ya...> ;Clinical Cancer Research. 2024 Mar 19
Future direction of total neoadjuvant therapy for locally advanced rectal cancer.
Yoshinori Kagawa, J Joshua Smith, Emmanouil Fokas, Jun Watanabe, Andrea Cercek, Florian R Greten, Hideaki Bando, Qian Shi, Julio Garcia-Aguilar, Paul B Romesser, Natal...> ;Nature Reviews. Gastroenterology & Hepatology. 2024 Mar 14
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
Lee, V., Parkinson, R., Zahurak, M., Cope, L., Verheul, H., Gootjes, E., Jones, P., Baylin, S., Rami, V., El Khoueiry, A., Cercek, A., Lenz, H., Iqbal, S., Ahuja, N., ...> ;International Journal of Cancer. 2024 May 15
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic Cholangiocarcinoma.
Harding, J., Sarah M McIntyre, William A Preston, Henry Walch, Jeremy Sharib, Ritika Kundra, Carlie Sigel, Michael E Lidsky, Peter J Allen, Michael A Morse, Wei Chen, ...> ;JCO Precision Oncology. 2024 Feb 1
1 citations
Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study.
Irit Ben-Aharon, Ran Rotem, Gilad Twig, Andrea Cercek, Elizabeth Half, Gabriel Chodik, David Kelsen, Melzer-Cohen, C., Goshen-Lago, T.> ;JMIR Public Health and Surveillance. 2023 Dec 13
ASO Visual Abstract: Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma.
Stijn Franssen, Jessica J Holster, Joshua S Jolissaint, Lynn E Nooijen, Andrea Cercek, Michael I D'Angelica, Marjolein Y V Homs, Alice C Wei, Vinod P Balachandran, Jef...> ;Annals of Surgical Oncology. 2024 Feb 1
Case-Based Clinical Guidance on Dosing and Management of the Hepatic Artery Infusion Chemotherapy Pump.
Devika Rao, Carleton S Ellis, Nancy Kemeny, Andrea Cercek> ;JCO Oncology Practice. 2024 Feb 1
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma.
Stijn Franssen, Jessica J Holster, Joshua S Jolissaint, Lynn E Nooijen, Andrea Cercek, Michael I D'Angelica, Marjolein Y V Homs, Alice C Wei, Vinod P Balachandran, Jef...> ;Annals of Surgical Oncology. 2024 Jan 1
2 citations
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade.
Emily C Harrold, Michael B Foote, Benoit Rousseau, Henry Walch, Yelena Kemel, Allison L Richards, Fergus Keane, Andrea Cercek, Rona Yaeger, Dana Rathkopf, Neil H Segal...> ;Nature Medicine. 2023 Oct 1
1 citations
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer.
Melissa A Lumish, Henry Walch, Steven B Maron, Walid Chatila, Yelena Kemel, Anna Maio, Geoffrey Y Ku, David H Ilson, Elizabeth Won, Jia Li, Smita S Joshi, Ping Gu, Mar...> ;Journal of the National Cancer Institute. 2024 Feb 8
ASO Visual Abstract: Combined Hepatic Artery Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liv...
Floris S Verheij, Koert F D Kuhlmann, Danielle R Silliman, Kevin C Soares, T Peter Kingham, Vinod P Balachandran, Jeffrey A Drebin, Alice C Wei, William R Jarnagin, An...> ;Annals of Surgical Oncology. 2023 Dec 1
2 citations
Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases.
Floris S Verheij, Koert F D Kuhlmann, Danielle R Silliman, Kevin C Soares, T Peter Kingham, Vinod P Balachandran, Jeffrey A Drebin, Alice C Wei, William R Jarnagin, An...> ;Annals of Surgical Oncology. 2023 Dec 1
5 citations
Efficacy of HER2-Targeted IntraperitonealAc α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.
Sebastian K Chung, Daniela Burnes Vargas, Christopher S Chandler, Sumudu Katugampola, Darren R Veach, Michael R McDevitt, Shin H Seo, Brett A Vaughn, Sara S Rinne, Ble...> ;Journal of Nuclear Medicine. 2023 Sep 1
The Impact of Germline Alterations in Appendiceal Adenocarcinoma.
Michael B Foote, Henry Walch, Yelena Kemel, Efsevia Vakiani, Paul Johannet, Margaret Sheehan, Walid Chatila, Sebastian Chung, Garrett M Nash, Anna Maio, Jinru Shia, Di...> ;Clinical Cancer Research. 2023 Jul 14
The impact of germline alterations in appendiceal adenocarcinoma.
Michael B Foote, Henry Walch, Yelena Kemel, Efsevia Vakiani, Paul Johannet, Margaret Sheehan, Walid Chatila, Sebastian Chung, Garrett Nash, Anna Maio, Jinru Shia, Dian...> ;Clinical Cancer Research. 2023 May 18
Reply to M.C. Strach et al.
Michael B Foote, Garrett M Nash, Andrea Cercek> ;Journal of Clinical Oncology. 2023 Jul 1
25 citations
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-la...
John H Strickler, Andrea Cercek, Salvatore Siena, Thierry André, Kimmie Ng, Eric Van Cutsem, Christina Wu, Andrew S Paulson, Joleen M Hubbard, Andrew L Coveler, Christ...> ;The Lancet. Oncology. 2023 May 1
Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome.
Megha Ranganathan, Rosalba E Sacca, Magan Trottier, Anna Maio, Yelena Kemel, Erin Salo-Mullen, Amanda Catchings, Sarah Kane, Chiyun Wang, Vignesh Ravichandran, Ryan Pt...> ;JCO Precision Oncology. 2023 May 1
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.
Kevin C Soares, Joshua S Jolissaint, Sarah M McIntyre, Kenneth P Seier, Mithat Gönen, Carlie Sigel, Naaz Nasar, Andrea Cercek, James J Harding, Nancy E Kemeny, Louise ...> ;Cancer Medicine. 2023 Jun 1
Incomplete cytoreductive surgery for appendiceal and colorectal peritoneal carcinomatosis: Characteristics and outcomes of an overlooked group.
Paolo Goffredo, Nicole Aguirre, Mostafa Mohamed, David A Kleiman, Andrea Cercek, J Joshua Smith, Philip B Paty, Martin Weiser, Garrett M Nash, Julio Garcia-Aguilar> ;Journal of Surgical Oncology. 2023 May 1
1 citations
Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma.
Melina E Marmarelis, Xiao Wang, Leonid Roshkovan, Connor B Grady, John T Miura, Michelle S Ginsberg, Christine A Ciunci, Jacklynn Egger, Suzanne Walker, Andrea Cercek,...> ;JAMA Network Open. 2023 Mar 1
367 citations
Colorectal cancer statistics, 2023.
Rebecca L Siegel, Nikita Sandeep Wagle, Andrea Cercek, Robert A Smith, Ahmedin Jemal> ;CA. 2023 Mar 1
Precision Management of a Patient With Dihydropyrimidine Dehydrogenase Deficiency and Liver-Predominant Metastatic Rectal Cancer Using Hepatic Arterial Floxuridine.
Melissa Lumish, Jennifer Thackray, Richard Kinh Gian Do, Kelly E Caudle, Ursula Amstutz, Matthias Schwab, Robert B Diasio, William R Jarnagin, Andrea Cercek> ;JCO Precision Oncology. 2023 Feb 1
1 citations
Clinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract Cancers.
Bill H Diplas, Ryan Ptashkin, Joanne F Chou, Shalom Sabwa, Michael B Foote, Benoit Rousseau, Guillem Argilés, James Robert White, Caitlin M Stewart, Kelly Bolton, Sree...> ;JAMA Network Open. 2023 Feb 1
83 citations
Treatment of Metastatic Colorectal Cancer: ASCO Guideline.
Van K Morris, Erin B Kennedy, Nancy N Baxter, Al B Benson 3rd, Andrea Cercek, May Cho, Kristen K Ciombor, Chiara Cremolini, Anjee Davis, Dustin A Deming, Marwan G Faki...> ;Journal of Clinical Oncology. 2023 Jan 20
Join now to see all

Journal Articles

Locoregional Therapy plus Systemic Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma—Reply
Andrea Cercek, MD, JAMA Oncology
Outcomes of Low-Grade Appendiceal Mucinous Neoplasms with Remote Acellular Mucinous Peritoneal Deposits
Jinru Shia, Garrett M Nash, Philip B Paty, Andrea Cercek, Campbell S Roxburgh, Annals of Surgical Oncology
Pelvic MRI After Induction Chemotherapy and Before Long-Course Chemoradiation Therapy for Rectal Cancer: What Are the Imaging Findings?
Andrea Cercek, Leonard Saltz, Marc J Gollub, Patricio Lynn, Martin R Weiser, European Radiology
Quantitative Imaging Features of Pretreatment CT Predict Volumetric Response to Chemotherapy in Patients with Colorectal Liver Metastases
Andrea Cercek, William R Jarnagin, Jinru Shia, Peter J Allen, Kenneth P Seastedt, Nancy E Kemeny, Ronald P DeMatteo, Vinod P Balachandran, T Peter Kingham, European Radiology
Join now to see all

Lectures

Gastrointestinal (Colorectal) Cancer
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Prevalence of germline genetic alterations in colorectal cancer patients.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Authored Content

Locoregional Therapy plus Systemic Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma—ReplyApril 2020

Press Mentions

Immunotherapy and… Nothing Else? Studies Test Potential Paradigm Shift in Cancer TreatmentFebruary 23rd, 2023
Biden Deserves Credit for Taking on Cancer: Cancer Moonshot PathwaysAugust 8th, 2022
Could This Immunotherapy Treatment Be a “Miracle Drug” for Fighting Cancer?June 28th, 2022
Join now to see all